Carr B.I.2024-08-042024-08-04202197830307873709783030787363https://doi.org/10.1007/978-3-030-78737-0https://hdl.handle.net/11616/92130This book aims to illuminate the causes, incidence, and treatments of Hepatocellular Carcinoma(HCC) or liver cancer in the politically important and societally diverse region of the Middle East. Taking a flexible and inclusive view, it examines the influences of geography, crops and diet, ethnicity, and local behavior on both diagnosis and outcomes of this disease. Understanding the different causes of liver cancer enables effective strategies for both prevention and early diagnosis while knowledge of the different treatment modalities, their uses and limitations, availability and costs, works to inform rational treatment provision and selection. Divided into four sections, this book considers the causes and clinical syndromes associated with HCC, provides a detailed overview of clinical HCC and treatment modalities, describes country-specific clinical HCC experience and practice, and considers future needs and the potential for HCC collaborations across the region. Liver Cancer in the Middle East is a useful resource for clinicians seeking insight into the second highest cause of death from cancer worldwide, governments planning social and medical services for their peoples, as well as for international aid agencies prioritizing donations. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021. All rights reserved.eninfo:eu-repo/semantics/closedAccessAflatoxinChemo-EmbolizationClinical Signs and SymptomsHBVHCC PhenotypingHCVImmune-Modulation TherapiesMolecular Targeted TherapiesRadio-EmbolizationBook141410.1007/978-3-030-78737-02-s2.0-85159722409N/A